• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Apple Tree Partners

Go sign green light
Biotech

Replicate's self-replicating RNA rabies vaccine clears phase 1

The Apple Tree Partners biotech showed all doses triggered protective responses, providing an initial sign of the potential of the platform.
Nick Paul Taylor Feb 14, 2024 8:54am
A photo of four apples suspended in the air blue sky out of focus in the background

Ex-Apple Tree investors launch new $310M fund for biotechs

Feb 7, 2024 6:00am
layoffs job cuts fired exit restructuring layoff reduction

Galvanize Therapeutics lays off employees

Jul 7, 2023 7:50am
three hand pact

Three-way merger nets $100M for pulsed electric field treatments

Sep 16, 2022 12:53pm
Dendritic cells

ATP launches in UK with Adendra Therapeutics

Dec 7, 2021 3:30am
Zhen Su

Marengo's $80M cancer battle led by ex-Merck KGaA oncology exec

Nov 8, 2021 8:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings